Sol-Gel Technologies Azioni (NASDAQ: SLGL)

Sol-Gel Technologies (NASDAQ:SLGL) Azioni, Quote.MetaTitle.unusual-options

Sol-Gel Technologies

Sol-Gel Technologies Ltd. - Ordinary Shares

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Comments

Sol-Gel Technologies Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO